Related Experiment Video
Updated: Jun 24, 2026
07:08
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
Protein expression profiles in pediatric multiple sclerosis: potential biomarkers
K N Rithidech1, L Honikel, M Milazzo
1Pathology Department, Stony Brook University, Stony Brook, NY, US. krithidech@notes.cc.sunysb.edu
Multiple Sclerosis (Houndmills, Basingstoke, England)
|March 28, 2009
Summary
Researchers identified 12 potential protein biomarkers in the blood of children with multiple sclerosis (MS). This proteomic analysis could improve early diagnosis and prognosis for pediatric MS.
Area of Science:
- Neurology
- Proteomics
- Biochemistry
Background:
- Pediatric multiple sclerosis (MS) diagnosis is difficult due to its rarity and overlap with other demyelinating disorders.
- Accurate diagnostic tools are needed to differentiate pediatric MS from similar conditions.
Purpose of the Study:
- To identify protein biomarkers in plasma that could aid in diagnosing pediatric MS.
- To explore the utility of proteomic techniques for pediatric MS biomarker discovery.
Main Methods:
- Utilized two-dimensional gel electrophoresis (2-DE) and mass spectrometry to analyze plasma protein expression.
- Compared protein patterns in nine children with MS against nine age- and gender-matched healthy controls.
Main Results:
- Identified 12 significantly upregulated proteins in pediatric MS patients.
- Key proteins include alpha-1-acid-glycoprotein 1, transthyretin, apolipoprotein-C-III, and complement factor-I.
- Demonstrated the sensitivity of 2-DE and mass spectrometry for biomarker identification.
Conclusions:
- Proteomic analysis reveals potential blood-based biomarkers for pediatric MS.
- These findings may lead to a new diagnostic and prognostic marker panel for pediatric MS.
- This approach highlights the potential of mass spectrometry in diagnosing rare pediatric neurological diseases.